Dr. Thomas Krivak
Claim this profileWest Penn Hospital
Expert in Ovarian Cancer
Studies Cancer
14 reported clinical trials
36 drugs studied
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
Stage II
2Cancer
Stage IV
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Thomas Krivak is currently running
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
Avutometinib + Defactinib
for Ovarian Cancer
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progressed on a prior platinum-based therapy.
Recruiting2 awards Phase 38 criteria
More about Thomas Krivak
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Thomas Krivak has experience with
- Paclitaxel
- Letrozole
- Topotecan
- Upifitamab Rilsodotin
- VB-111
- Ribociclib
Breakdown of trials Thomas Krivak has run
Ovarian Cancer
Cancer
Relapse
Serous Cystadenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Krivak specialize in?
Thomas Krivak focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Thomas Krivak currently recruiting for clinical trials?
Yes, Thomas Krivak is currently recruiting for 2 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Thomas Krivak has studied deeply?
Yes, Thomas Krivak has studied treatments such as Paclitaxel, Letrozole, Topotecan.
What is the best way to schedule an appointment with Thomas Krivak?
Apply for one of the trials that Thomas Krivak is conducting.
What is the office address of Thomas Krivak?
The office of Thomas Krivak is located at: West Penn Hospital, Pittsburgh, Pennsylvania 15224 United States. This is the address for their practice at the West Penn Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.